Skip Navigation Links
Stethoscope

Projects in the news

News

7 September 2015 - Project developing fun 3D vision test for children wins patient and public involvement award

A Health Innovation Challenge Fund project was awarded second place for patient and public involvement at the recent Bright Ideas in Health Awards.


Read the full news item

12 March 2015 – Large scale discovery of 12 novel genes associated with developmental disorders

The findings of The Deciphering Developmental Disorders Study which was funded by the Wellcome Trust and the Department of Health through the Health Innovation Challenge Fund, have been published in Nature.

Read the full press report

24 December 2014 - Project pinpoints 12 new genetic causes of developmental disorders

The first results to emerge from a nationwide project to study the genetic causes of rare developmental disorders have revealed 12 causative genes that have never been identified before. The Deciphering Developmental Disorders (DDD) project, the world's largest, nationwide genome-wide diagnostic sequencing programme, sequenced DNA and compared the clinical characteristics of over a thousand children to find the genes responsible for conditions that include intellectual disabilities and congenital heart defects, among others.

Read the full press report

03 July 2014 - Android tablet app can help patients manage their own long-term condition

An Android tablet-based digital mobile health system to support patients with chronic obstructive pulmonary disease (COPD) has been found to improve quality of care and aid self-management at home, according to a study funded by the Wellcome Trust and the Department of Health through the Health Innovation Challenge Fund.

Read the full press report

30 January 2014 – Syncona to invest £12m into gene therapies for blindness following results from successful HIC Fund project

Nightstar, a new spin-out company, is to receive a £12 million investment from Syncona to develop and commercialise therapies for retinal dystrophies – degenerative conditions that affect vision.

The announcement follows promising results earlier this month from the first clinical trial of a gene therapy, developed by Professor Robert MacLaren of Oxford university and colleagues, for an inherited form of progressive blindness called choroideremia. The trial is funded by the Health Innovation Challenge Fund, a partnership between the Wellcome Trust and the Department of Health.

Read the full press report

16 January 2014 - Gene therapy trial shows promise for type of blindness

The first clinical trial of a gene therapy for an inherited cause of progressive blindness called choroideremia has shown very promising initial results.

The clinical trial is funded by the Health Innovation Challenge Fund, a partnership between the Wellcome Trust and the Department of Health.

Read the full press report